Related references
Note: Only part of the references are listed.Computational analyses of interactions between ALK-5 and bioactive ligands: insights for the design of potential anticancer agents
Michell O. Almeida et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists
Sara Guariento et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands
Sara Guariento et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives
Silvia Franchini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
In silico studies on the interaction between bioactive ligands and ALK5, a biological target related to the cancer treatment
Michell O. Almeida et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2016)
Exhaustive 3D-QSAR analyses as a computational tool to explore the potency and selectivity profiles of thieno[3,2-d] pyrimidin-4(3H)-one derivatives as PDE7 inhibitors
Elena Cichero et al.
RSC ADVANCES (2016)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
ALK-5 Inhibition: A Molecular Interpretation of the Main Physicochemical Properties Related to Bioactive Ligands
Sheila C. Araujo et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2015)
Recent Advances in Multidimensional QSAR (4D-6D): A Critical Review
Manoj G. Damale et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2014)
Computational studies of TGF-βRI (ALK-5) inhibitors: Analysis of the binding interactions between ligand-receptor using 2D and 3D techniques
Sheila C. Araujo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: Improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy
Youichi Kawakita et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Design and Synthesis of Pyrrolo[3,2-d]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket Binders
Youichi Kawakita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
Kathleen Aertgeerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold
Tomoyasu Ishikawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Two-Dimensional Quantitative Structure-Activity Relationship Studies on Bioactive Ligands of Peroxisome Proliferator-Activated Receptor delta
Tabata S. Garcia et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2011)
Structure-Based Virtual Screening
Walter Filgueira De Azevedo
CURRENT DRUG TARGETS (2010)
QUANTUM CHEMICAL PROPERTIES USED IN STRUCTURE-ACTIVITY RELATIONSHIP STUDIES.
Agnaldo Arroio et al.
QUIMICA NOVA (2010)
Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines
D. W. Rusnak et al.
CELL PROLIFERATION (2007)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Share Paper
